MGMT-unmethylated glioblastoma

Clinical trials for MGMT-unmethylated glioblastoma explained in plain language.

Never miss a new study

Get alerted when new MGMT-unmethylated glioblastoma trials appear

Sign up with your email to follow new studies for MGMT-unmethylated glioblastoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 5 Not yet finished but already full! 1 Completed 1 Terminated 1

Experimental drug navtemadlin tested for glioblastoma

Disease control Stopped early

This early-phase trial tested the drug navtemadlin in 32 adults with glioblastoma, a type of brain cancer. The study aimed to find the best dose and check side effects, both for newly diagnosed and recurrent cases. The trial was terminated early, so results are limited.

Matched conditions: MGMT-UNMETHYLATED GLIOBLASTOMA

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

MGMT-unmethylated glioblastoma

Get alerted when new MGMT-unmethylated glioblastoma trials appear

Experimental drug navtemadlin tested for glioblastoma